This is The Dawning of The Age of (Turnkey) Aquarius (HAIR)

Surprisingly, this dawning meant a drop of over 11% for Biostem U.S. (OTC: HAIR) earlier today.

Biostem U.S. is a Nevada corporation with offices in Clearwater, Florida, that intends to help men and women overcome unwanted baldness. The company intends to facilitate this cure by helping stimulate hair growth through the use of platelet-rich plasma injections, low-level laser therapy, nutraceutical supplements to stimulate stem cell growth, and private labeled hair products. The company is presently marketing the program as the Biostem Method.

This is, of course, is not to say that baldness is not sexy to some. Rather that the majority of people in this world are not terrifically interested in looking like Mr. Clean.

It was a touch over two weeks ago that Biostem announced that The Pizarro Hair Restoration Clinic in Orlando, Florida, was finally ready to begin offering this alternative to hair transplants through the use of the patient’s own stem cells. Additionally, the company announced that Dr. Marina Pizarro would also soon be ready to begin training others in its proprietary method. This came on the heels of Dr. Pizarro completing her first two treatments. Oddly, or at least surprisingly, both of these treatments were administered to women.

Perhaps, given that men are more prone to hair loss, the company may have been better served having treated men as the stock has steadily declined since the announcement on August 13, 2012. On the day of the news, the stock was trading at $0.24. Biostem opened the day just above $0.225 before dropping sharply to just over $0.16. Thankfully for investors and Biostem, the stock recovered throughout the day closing at $0.186 on heavy trading. Over a million shares were traded today from a company that has averaged a volume of just over 61,000 shares during the last three months.

This drop of over 11% today came in spite of promotions by both The Lightning Picks and Penny Stock Finder. This surprise (?) drop also occurred after Biostem announced that it was ready to begin offering turnkey opportunities around the country. This is supposedly based on a large number of inquiries.

It was Biostem’s CEO, Dwight Brunoehler, who said, “On the heels of Dr. Marina Pizarro’s initial hair replacement procedures using The Biostem Method™, the Company is now fully prepared to offer and support turnkey operations that will provide its proprietary hair regrowth technology to qualified physicians and clinics in the U.S. This service provides equipment, on site set up, training, operational protocols, marketing assistance, a fully staffed training facility, and on-going support. Our intention is to make this as easy as possible for affiliates to become involved. After entering into an agreement, physicians will be able to offer Biostem services in their offices within eight weeks. It is expected that hair replacement clinics in New York, California, Texas and other metropolitan centers known for the popularity of cosmetic procedures will be on board The Biostem Method™ before the end of the year.”

Keep an eye on Biostem. Quite frankly, it may just be a matter of time to show the world that its treatment does indeed work. Countless thousands of bald people have spent untold millions of dollars rather than listening to the words of the philosopher Daltrey when he wisely said, “We won’t get fooled again.”

For consideration of being featured on WallstreetPR, contact:

Please make sure to read and completely understand our disclaimer at FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any content posted on our website is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. WallStreetPR strongly recommends you consult a licensed or registered professional before making any investment decision. Neither nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. WallStreetPR often gets compensated for advertisement services that are disclosed on our disclaimer located at

Published by Brendan Byrne

While studying economics, Brendan found himself comfortably falling down the rabbit hole of restaurant work, ultimately opening a consulting business and working as a private wine buyer. On a whim, he moved to China, and in his first week following a triumphant pub quiz victory, he found himself bleeding on the floor based on his arrogance. The same man who put him there offered him a job lecturing for the University of Wales in various sister universities throughout the Middle Kingdom. While primarily lecturing in descriptive and comparative statistics, Brendan simultaneously earned an Msc in Banking and International Finance from the University of Wales-Bangor. He's presently doing something he hates, respecting French people. Well, two, his wife and her mother in the lovely town of Antigua, Guatemala. You may contact Brendan via his email ( or his Google+ page (